CREFX | IRSEX | CREFX / IRSEX | |
Total Expense Ratio | 0.75 | 0.80 | 94% |
Annual Report Gross Expense Ratio | 0.75 | 1.06 | 71% |
Fund Existence | 8 years | 11 years | - |
Gain YTD | 5.114 | 2.270 | 225% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.03B | 91.3M | 8,793% |
Annual Yield % from dividends | 2.58 | 1.78 | 145% |
Returns for 1 year | 11.68 | 0.75 | 1,560% |
Returns for 3 years | 12.84 | -29.32 | -44% |
Returns for 5 years | 38.61 | -20.33 | -190% |
Returns for 10 years | N/A | -31.03 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NSNCX | 46.96 | 0.44 | +0.95% |
Neuberger Berman Small Cap Growth C | |||
ECEOX | 12.06 | 0.08 | +0.67% |
Lazard Emerging Markets Core Equity Open | |||
CVMAX | 20.19 | 0.10 | +0.50% |
Calvert Emerging Markets Equity A | |||
MSVMX | 5.35 | 0.02 | +0.38% |
Morgan Stanley Vitality Portfolio C | |||
SVFAX | 76.58 | -0.29 | -0.38% |
Smead Value A |